Dc Investments Management, LLC Gilead Sciences, Inc. Transaction History

Dc Investments Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $556,860 - $635,377	-9,281 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $171,536 - $195,457	-3,028 Reduced 24.6%	9,281 $541,000
Q3 2020 Nov 04, 2020	BUY	$62.1 - $78.08 $479,474 - $602,855	7,721 Added 168.29%	12,309 $778,000
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $4.91 Million - $5.7 Million	-67,862 Reduced 93.67%	4,588 $353,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $4.54 Million - $5.81 Million	72,450 New	72,450 $5.42 Million

Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $310,934 - $342,017	-5,046 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $101,516 - $112,056	1,624 Added 47.46%	5,046 $320,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $211,719 - $237,418	3,422 New	3,422 $231,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dc Investments Management, LLC with notifications on news.